Timing of antiretroviral therapy and TB treatment outcomes in patients with TB-HIV in Myanmar - Wikidata - wikimedia - TriplyDB

Timing of antiretroviral therapy and TB treatment outcomes in patients with TB-HIV in Myanmar

Timing of antiretroviral therapy and TB treatment outcomes in patients with TB-HIV in Myanmar

http://www.wikidata.org/entity/Q30383131

about

The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study.

P2860

Q40095857-453236E0-6190-4F79-B97F-158696443902

P2860

Timing of antiretroviral therapy and TB treatment outcomes in patients with TB-HIV in Myanmar

http://www.wikidata.org/entity/Q30383131

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Timing of antiretroviral thera ...... atients with TB-HIV in Myanmar

@ast

Timing of antiretroviral thera ...... atients with TB-HIV in Myanmar

@en

type

label

Timing of antiretroviral thera ...... atients with TB-HIV in Myanmar

@ast

Timing of antiretroviral thera ...... atients with TB-HIV in Myanmar

@en

prefLabel

Timing of antiretroviral thera ...... atients with TB-HIV in Myanmar

@ast

Timing of antiretroviral thera ...... atients with TB-HIV in Myanmar

@en

P1433

Q30383131-22D2D6BD-A0E1-4534-B43D-97B599A44B22

P1476

Q30383131-BE77F351-ED6F-4E88-97BF-6C4FB0111736

P2093

Q30383131-014A0824-D819-42A5-AA5A-E7504470869E

Q30383131-0B26A167-379D-4C71-877C-D5771FADACCD

Q30383131-274AC8A3-C115-475E-B9F6-968F83904F67

Q30383131-305737ED-51E6-4239-8E0F-6CAE45E3BC60

Q30383131-99F4CB51-3DA5-48F9-A1FC-E8B070AE2F5E

Q30383131-B19E6696-B14A-4659-9A07-4157E7D87630

Q30383131-D4520387-D400-438C-B7E9-E9363BF13D6E

Q30383131-EB67E7A9-BEA0-4437-91E4-C34B7EB75256

P2860

Q30383131-09E4C933-6FDF-4171-BFC6-79FC8E9F6BBD

Q30383131-0E1B16BC-8D47-4DDF-A73D-21D379096E4C

Q30383131-1D63E2AC-CE36-4386-B28A-F63B9FC7A71D

Q30383131-31C782B1-E1F0-4410-8675-EA142BEBA940

Q30383131-3DEBD2BE-EB87-47C5-A4D3-EFDF97FFA41D

Q30383131-52AF721C-8976-4E92-BB40-53834EE52BC9

Q30383131-58E65B2C-DD29-41E8-B6ED-C4A1FD6B4A10

Q30383131-62A772CA-20B7-4378-9E72-C8813D4B5E40

Q30383131-7B0A1EB2-2D5A-4FFE-9882-6EA1A80AD573

Q30383131-8071182F-7CD2-4A3A-9169-B72ED5854D29

P304

Q30383131-D0194803-C150-425C-A617-B895E3914751

P31

Q30383131-5416BF92-CBB0-4A6B-B6DF-C7EFB0524AE4

P356

Q30383131-5D0CD4AF-08EC-4963-A3E2-9F72499966E4

P433

Q30383131-0A12E816-CF0A-4728-ABAB-2E046C9335FB

P478

Q30383131-67488141-748E-4772-9B28-632D31B8E930

P50

Q30383131-DF65516E-5826-4292-BAFE-5A3E43E7FBF5

P577

Q30383131-D7FFCC19-DCFF-410B-AA06-52375488DD8B

P698

Q30383131-7727AFF9-C5EE-4E25-9A6B-1D5BCD97A71E

P921

Q30383131-B4164087-E502-42C8-AEEA-13CCBE89D2EA

P932

Q30383131-CA313EF3-F95D-4A28-A08A-A1316D3E5EB5

P356

P1433

Public health action

P1476

Timing of antiretroviral thera ...... atients with TB-HIV in Myanmar

@en

P2093

A D Harries

http://www.w3.org/2001/XMLSchema#string

A M Thi

http://www.w3.org/2001/XMLSchema#string

H N Oo

http://www.w3.org/2001/XMLSchema#string

M M Oo

http://www.w3.org/2001/XMLSchema#string

N T T Kyaw

http://www.w3.org/2001/XMLSchema#string

S T Aung

http://www.w3.org/2001/XMLSchema#string

T K Aung

http://www.w3.org/2001/XMLSchema#string

T Win

http://www.w3.org/2001/XMLSchema#string

P2860

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study

Retention and risk factors for attrition in a large public health ART program in Myanmar: a retrospective cohort analysis.

High mortality among patients with AIDS who received a diagnosis of tuberculosis in the first 3 months of antiretroviral therapy.

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

The impact of antiretroviral therapy on mortality in HIV positive people during tuberculosis treatment: a systematic review and meta-analysis.

HIV-associated tuberculosis: relationship between disease severity and the sensitivity of new sputum-based and urine-based diagnostic assays.

Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial

P304

111-117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5588/PHA.16.0009

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Hemant Deepak Shewade

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27358804

http://www.w3.org/2001/XMLSchema#string

P921

P932

4913673

http://www.w3.org/2001/XMLSchema#string